[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341329-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341329-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","diagnostic-and-prognostic-value-of-methyltransferase-like-13-in-hepatocellular-carcinoma-based-on-bioinformatics-analysis-original-article","Diagnostic and Prognostic Value of Methyltransferase Like 13 in Hepatocellular Carcinoma Based on Bioinformatics Analysis - Original Article","","Hepatocellular carcinoma (HCC) remains a malignancy with high incidence and mortality, and reliable early diagnostic as well as prognostic biomarkers are urgently needed. This study used bioinformatics to evaluate methyltransferase like 13 (METTL13) in HCC by analyzing TCGA mRNA data and survival curves generated with R 4.2.1, plus Cox regression based on tumor stage and METTL13 expression. The GSE114564 dataset assessed serum METTL13 differences between early HCC and non-cancer controls, and receiver operating characteristic analysis quantified diagnostic performance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/diagnostic-and-prognostic-value-of-methyltransferase-like-13-in-hepatocellular-carcinoma-based-on-bioinformatics-analysis-original-article/341329/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/diagnostic-and-prognostic-value-of-methyltransferase-like-13-in-hepatocellular-carcinoma-based-on-bioinformatics-analysis-original-article/341329.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the goal of this study on METTL13 in HCC?","Question",{"text":63,"@type":64},"To explore the diagnostic and prognostic utility of methyltransferase like 13 (METTL13) in patients with hepatocellular carcinoma using bioinformatics analysis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which data sources were used to evaluate METTL13?",{"text":68,"@type":64},"The study used TCGA for mRNA and survival analyses and the GSE114564 dataset from the Gene Expression Omnibus to assess serum METTL13 levels in early HCC versus non-cancer controls.",{"name":70,"@type":61,"acceptedAnswer":71},"What main conclusions were reported regarding METTL13?",{"text":72,"@type":64},"High METTL13 expression was associated with worse overall survival in HCC, and serum METTL13 showed a moderate diagnostic value for early HCC.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341329,1790197998,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":102,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","ORIGINAL ARTICLE LIVER  \nDiagnostic and Prognostic Value of Methyltransferase Like 13 in Hepatocellular Carcinoma Based on Bioinformatics Analysis  \nYuanzhang Wen, Jiwei Xu, Huancheng Zhou, Wanwei Liu  \nDepartment of Hepatobiliary Surgery, Meizhou People’s Hospital, Meizhou, Guangdong, China  \nCite this article as: Wen Y, Xu J, Zhou H, Liu W. Diagnostic and prognostic value of methyltransferase like 13 in hepatocellular carcinoma based on bioinformatics analysis. Turk J Gastroenterol. 2024;35(5):385-390 .  \nABSTRACT  \nBackground/Aims: Hepatocellular carcinoma (HCC) is one of the cancers with the highest incidence and mortality rates. This study aims to explore the diagnostic and prognostic utility of methyltransferase like 13 (METTL13) in patients with HCC via bioinformatics analysis. Materials and Methods: We obtained mRNA data of HCC from the database of the Cancer Genome Atlas (TCGA), drawing survival curve by R 4.2.1 software. Cox regression analysis was conducted based on tumor stage and METTL13 expression. The GSE114564 dataset was chosen from the Gene Expression Omnibus. The differences in serum METTL13 levels between the groups of early HCC (eHCC) and non-cancer controls were evaluated. Using a receiver operating characteristic curve, we calculated the area under the curve (AUC) of serum METTL13 for diagnosing eHCC.  \nResults: A total of 225 cases with HCC were screened from TCGA, and 29 cases were normal controls. The results showed that the METTL13 expression in the HCC group was higher than that in the normal controls (P \u003C .001). The univariate [hazard ratio (HR) = 1.895, P = .006] and multivariate Cox regression (HR = 1.702, P = .037) analyses showed that high METTL13 expression reduced overall survival in HCC. Serum METTL13 levels were higher in the eHCC group than in the non-cancer controls (P = . 008). The optimum AUC for predicting eHCC by serum METTL13 was 0.7091.  \nConclusion: Serum METTL13 has a moderate diagnostic value for eHCC. High METTL13 expression is correlated with a worse prognosis in patients with HCC. Methyltransferase like 13 possesses the potential to be a novel biomarker for HCC.  \nKeywords: METTL13, hepatocellular carcinoma, bioinformatics analysis, prognostic value  \nINTRODUCTION  \nAccounting for about 75%-85% of primary liver cancer, hepatocellular carcinoma (HCC) is one of the cancers with the highest incidence rate, which ranks fifth worldwide.1 Moreover, it is the fourth most common cancer-related cause of death in the world.2 Hepatocellular carcinoma is a high-grade malignant tumor. Even after successful radical resection, it still shows the characteristics of rapid invasive growth, early metastasis, and poor prognosis.3,4 Since the early symptoms of HCC are not typical and the lesions are small, it is challenging to detect early HCC (eHCC). When patients with HCC show symptoms, most of them are in the advanced stage and usually have a poor prognosis. Early detection of HCC is the most critical step in the treatment process. Therefore, it is important to identify diagnostic and prognostic markers for patients with tumors.  \nMethyltransferase like 13 (METTL13), also known as faint expression in normal tissues, aberrant overexpression in  \ntumors (FEAT), localized at 1q24.3, was originally identified as an inhibitor of nuclear apoptosis in rat brains.5 Studies reported that METTL13 expression was upregulated in liver cancer,6 breast cancer, lung cancer,7 and head and neck cancers.8 Liu et al9 showed that METTL13-mediated K55 methylation of eukaryotic translation elongation factor-1A (eEF1A) promoted tumorigenicity. In addition, METTL13 inhibited the progression of clear cell renal cell carcinoma through phosphatidylinositol 3-kinase/protein kinase B (AKT)/mammalian target of the rapamycin/hypoxia-inducible factor-1 alpha pathway.10 In HCC, hematological and neurological expressed 1-like (HN1L)-mediated transcription axis activator protein 2 gamma/METTL13/transcription factor 3 zinc finger ","cbCaicbzdPbszqEY","https://ap.wps.com/l/cbCaicbzdPbszqEY","pdf",531870,"English","# Abstract\n# Introduction\n# Materials and Methods\n## The Cancer Genome Atlas Database Download\n## Survival Curve Drawing","[{\"question\":\"What is the goal of this study on METTL13 in HCC?\",\"answer\":\"To explore the diagnostic and prognostic utility of methyltransferase like 13 (METTL13) in patients with hepatocellular carcinoma using bioinformatics analysis.\"},{\"question\":\"Which data sources were used to evaluate METTL13?\",\"answer\":\"The study used TCGA for mRNA and survival analyses and the GSE114564 dataset from the Gene Expression Omnibus to assess serum METTL13 levels in early HCC versus non-cancer controls.\"},{\"question\":\"What main conclusions were reported regarding METTL13?\",\"answer\":\"High METTL13 expression was associated with worse overall survival in HCC, and serum METTL13 showed a moderate diagnostic value for early HCC.\"}]","Diagnostic and Prognostic Value of Methyltransferase Like 13 in Hepatocellular Carcinoma Based on Bioinformatics Analysis - Original Article | PDF",1790041552,15,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e488db960f61e434257ee479bdbe1a8.webp",983,1280,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2858ba14ba0d41b429146159672191b8.webp",982,1278,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2e16fa7572992af6612d0144ddb68722.webp",981,1277,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17346eb8ccd0e2dc72d07106496d1178.webp",980,1276]